BIOTRONIK Blog

Cardiovascular research has achieved a lot in the last few decades—but even today the cardiology community is discussing whether the field needs gender-specific guidelines for treating cardiovascular diseases. One of the biggest obstacles is one of the most common problems in scientific research—a simple lack of data.

It’s hard to think of information that feels more personal than data about our own health. Yet we’re generating and monitoring more health data now than ever before. Whether it’s specific technology designed to help manage certain medical conditions—such as BIOTRONIK’s Patient App or remote care with Home Monitoring—or the plethora of more general, consumer-grade wearables and health apps, there are more and more digital options to help manage patient health.

An American survey last year found that health-related goals topped the priority list of New Year’s resolutions for 2021. Around half of those surveyed wanted to exercise more or lose weight, while about 40 percent wanted to improve their diets and 10 percent wanted to quit smoking. Of those people who make resolutions, many say they do, in fact, keep them. Around half of respondents in one such survey said they kept at least some of their 2020 resolutions. About 35 percent said they met all of their goals and just 16 percent say they didn’t keep any of their resolutions.

How a CLS Pacemaker Helps Cabaret Artist Wolfgang Koch Live Life to the Fullest

Prof. Anders Wanhainen Highlights New ESVS Recommendations, Advising on Suspended Personal Radiation Protection Systems for the First Time

What began with one lifesaving mission between two students in early 1960s Berlin now spans the globe: BIOTRONIK is active in more than 100 countries.

The first patient visit to BIOTRONIK in a long while met with excitement and enthusiasm

How New Strategies Move Beyond Simple AF Detection to Focus on Reducing AF Burden and Monitoring Disease Progression

After starting enrollment in 2019, Dr. Valentina Kutyifa announced the first results of the BIOTRONIK-supported BIO-LIBRA trial at the Annual Heart Rhythm Society meeting (HRS 2022).